This report presents the results of the second edition of the Quality of Official Development Assistance (QuODA) assessment, with a focus on the changes that have occurred in donor performance since the first edition (2008).
The international affairs portion of the president’s FY2013 budget will likely generate concern among aid advocates over cuts to health and humanitarian assistance.
This report of the Rethinking U.S. Foreign Assistance Program summarizes the rationale for continued U.S. investment in global health, looks into the evolution of the Global Health Initiative, and recommends a re-boot for the whole enterprise.
As the Global Health Initiative moves into its third year of implementation, Nandini Oomman and Rachel Silverman summarize the current status of this major development initiative, highlight the challenges for the GHI, and propose specific recommendations for a way forward.
Which Countries Pass the FY2012 Selection Hard Hurdles? A Preview into Round 9 of the Millennium Challenge Corporation’s Country Selection
This note offers a preliminary assessment of MCC candidate country scores on the FY2012 hard hurdles.
Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Diseases
This report of the Working Group on Clinical Trials and Regulatory Pathways provides practical policy recommendations to help provide better, safer, and cheaper medicine and treatment to the 1 billion people suffering from neglected diseases.
This report takes a look at the Obama administration's FY2012 budget request and congressional reaction to gauge the potential for implementing foreign aid reforms as spelled out in the administration's policy documents.
In a new CGD report, U.S. and Pakistani development experts urge a substantial revamp of the U.S. approach to Pakistan, saying that U.S. efforts to build prosperity in the nuclear-armed nation with a fledgling democratic government, burgeoning youth population, and shadowy intelligence services are not yet on course.
Growing Business or Development Priority? Multilateral Development Banks' Direct Support to Private Firms
Private sector lending by international financial institutions (IFIs) is soaring. Guillermo Perry finds it’s a mixed bag and suggests improvements, including more support to small and medium firms and avoidance of procyclical lending.
The time is right to reinvigorate UNFPA. Seventeen years after the groundbreaking ICPD meeting, UNFPA needs to make itself the lead agency for population, sexual and reproductive health, and reproductive rights in the UN system, as well as be more visible externally.
This report offers a snapshot analysis of the Republic of Georgia’s Millennium Challenge Corporation (MCC) compact implementation.
In this report John Simon and Julia Barmier assess past and current efforts to indicate whether direct development investment is worth promoting as a matter of public policy.
This analysis draws upon two recent congressionally mandated reports and country indicator performance to predict which countries the MCC board will select as eligible to apply for FY2011 compact or threshold assistance.
The Prevention of Odious Debt Working Group proposes a new tool to alleviate the burden that unjust transactions impose on successor governments and their citizens.
QuODA is an assessment of the Quality of Official Development Assistance provided by 23 countries and more than 150 aid countries.
This report focuses on the workforce strengthening strategies of three of the major HIV/AIDS donors—the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), and the World Bank’s Africa Multi-country HIV/AIDS Program (the MAP)—and identifies six tasks for donors, national governments, and country stakeholders to undertake to reverse the severe shortage of skilled, motivated, and productive health workers.
In an increasingly interconnected world, drug resistance does not stop at a patient’s bedside—it threatens global health. The conclusions of the Center for Global Development’s Drug Resistance Working Group make clear the need for urgent action to address this growing crisis.
This report examines the use of performance-based funding (PBF) among the big three funders of HIV/AIDS programs in developing countries: the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to Fight AIDS Tuberculosis and Malaria, and the World Bank’s Multi-Country HIV/AIDS Program for Africa (the MAP).